Formus Atlas
Cloud-based AI-automated image segmentation, landmarking and measurements as a service
Api · Cloud SaaSCompany source
Company profile
About Formus Labs, Ltd
Formus Labs is an orthopaedic software development company creating world-first solutions for joint replacement surgeries. Founded from within the world-renowned Auckland Bioengineering Institute in New Zealand, Formus Labs combines cutting-edge computational biomechanics and AI automation to deliver personalized orthopaedic care at scale. Their flagship product, Formus Hip, is the world's first cloud-based AI-automated 3D pre-operative planning software for primary total hip arthroplasty, transforming patient CT scans into ready-to-execute surgical plans in under an hour. The platform empowers surgeons with patient-specific implant selection and placement recommendations, optimizing fit and function while significantly reducing planning time. Formus Labs serves orthopaedic surgeons and healthcare providers globally, with established partnerships in Australia, New Zealand, Japan, and recent FDA clearance enabling US market expansion. The company's technology addresses the growing demand for joint replacement surgeries—expected to reach nearly four million procedures annually by 2030—by making sophisticated pre-operative planning scalable and accessible. Beyond Formus Hip, the company is developing Formus Atlas for automated image segmentation and measurements, and Formus Navigator for comprehensive pre-, intra-, and post-operative guidance with soft-tissue modelling. The platform delivers significant cost reductions (up to 25%), greater workflow efficiency through remote case planning, and a unified approach linking pre-op imaging with intra-operative guidance.
Company description Formus Labs, Ltd official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Formus Labs, Ltd?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Hip reconstruction
- Joint replacement surgeries
- Primary osteoarthritis
- Primary total hip arthroplasty
Who it serves
- Health systems
- Hospitals
- Medical device companies
- Orthopaedic surgeons
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsAustralia · International markets · Japan · New Zealand · United States
Company sourceOfficial website
Company milestones
Platform expansion
FDA 510(k) clearance December 2024; Exclusive partnership with Zimmer Biomet for Japanese market October 2025; Appointment of Prof. Yasuhiro Homma as Japanese clinical advisor; Hired Polly Teevan (ex-J&J) as CMO; Added Lloyd McCann and Meraj Khan to Board of Directors
Partnerships
Recorded partners
- Auckland Bioengineering Institute
- GD1 (investor/board member)
- Zimmer Biomet (exclusive distribution in Australia, New Zealand, and Japan)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Formus Hip
World's first AI-automated 3D pre-operative planning software for primary total hip arthroplasty
Software · Cloud SaaSCompany source
Formus Navigator
Pre-, intra-, and post-op guidance with soft-tissue modeling for joint replacement
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Formus HipK213272 · 510k · Mar 31, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
25% cost reduction
Reduction in joint replacement costs by eliminating manual image segmentation, limiting inventory shipping and sterilisation costs, and reducing revision risk
Under 60 minutes
Scan-to-plan time for generating fully interactive 3D surgical plans
Zero adverse outcomes
No known adverse outcomes across 3,500+ THAs in Australia and New Zealand
Multiple Japanese surgeons and patients
18-month evaluation period with Japanese surgeons and patients to adapt Formus Hip product to fit unique needs of Japanese market
Product successfully adapted for Japanese market, leading to exclusive distribution agreement with Zimmer Biomet Japan
Zimmer Biomet Australia & New Zealand
Five year partnership using Formus Hip for AI-automated 3D pre-operative planning for total hip arthroplasty across Australia and New Zealand market
Successfully planned and delivered over 3,500 THAs with no known adverse outcomes, going from scan-to-plan in under 60 minutes
John Flynn Gold Coast Private Hospital
Primary total hip arthroplasty for patient with end-stage primary osteoarthritis and tight canal distally limiting stem size. Used Formus Platform to plan hip reconstruction based on stem position with patient-specific cup position and version.
Successful hip reconstruction with optimal stem fit, cup position and version despite anatomical constraints
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Formus Labs, Ltd
Recent articles published on Formus Labs, Ltd's official website.
Formus Appoints Renowned Orthopaedic Surgeon Prof. Yasuhiro Homma as Clinical Advisor
Read on Formus Labs, LtdFormus Labs Hip Platform Receives FDA Clearance!
Read on Formus Labs, LtdFormus and Zimmer Biomet enter into an exclusive partnership for the Japanese market
Read on Formus Labs, LtdFormus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy
Read on Formus Labs, LtdFormus Labs Adds Seasoned Medical Technology Executives Lloyd McCann and Meraj Khan to Board of Directors
Read on Formus Labs, Ltd07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.